+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Osteoarthritis Pain Drug Market Research Report by Drug Class, by Route of Administration, by State - United States Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5123802
  • Report
  • September 2021
  • Region: United States
  • 83 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The United States Osteoarthritis Pain Drug Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Osteoarthritis Pain Drug Market.

Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Osteoarthritis Pain Drug to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Drug Class, the Osteoarthritis Pain Drug Market was studied across Corticosteriods, NSAIDs, and Viscosupplementation.
  • Based on Distribution Channel, the Osteoarthritis Pain Drug Market was studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Route of Administration, the Osteoarthritis Pain Drug Market was studied across Oral, Parenteral, and Topical.
  • Based on State, the Osteoarthritis Pain Drug Market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Osteoarthritis Pain Drug Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Osteoarthritis Pain Drug Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Osteoarthritis Pain Drug Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Osteoarthritis Pain Drug Market?
4. What is the competitive strategic window for opportunities in the United States Osteoarthritis Pain Drug Market?
5. What are the technology trends and regulatory frameworks in the United States Osteoarthritis Pain Drug Market?
6. What is the market share of the leading vendors in the United States Osteoarthritis Pain Drug Market?
7. What modes and strategic moves are considered suitable for entering the United States Osteoarthritis Pain Drug Market?
Note: Product cover images may vary from those shown
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Drug Class Outlook
3.4. Distribution Channel Outlook
3.5. Route of Administration Outlook
3.6. State Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges

6. Osteoarthritis Pain Drug Market, by Drug Class
6.1. Introduction
6.2. Corticosteriods
6.3. NSAIDs
6.4. Viscosupplementation

7. Osteoarthritis Pain Drug Market, by Distribution Channel
7.1. Introduction
7.2. Hospital Pharmacies
7.3. Online Pharmacies
7.4. Retail Pharmacies

8. Osteoarthritis Pain Drug Market, by Route of Administration
8.1. Introduction
8.2. Oral
8.3. Parenteral
8.4. Topical

9. California Osteoarthritis Pain Drug Market
9.1. Introduction

10. Florida Osteoarthritis Pain Drug Market
10.1. Introduction

11. Illinois Osteoarthritis Pain Drug Market
11.1. Introduction

12. New York Osteoarthritis Pain Drug Market
12.1. Introduction

13. Ohio Osteoarthritis Pain Drug Market
13.1. Introduction

14. Pennsylvania Osteoarthritis Pain Drug Market
14.1. Introduction

15. Texas Osteoarthritis Pain Drug Market
15.1. Introduction

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
FIGURE 3. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD MILLION)
FIGURE 4. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 (USD MILLION)
FIGURE 5. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 6. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 7. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET: MARKET DYNAMICS
FIGURE 8. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (%)
FIGURE 9. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2026
FIGURE 11. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CORTICOSTERIODS, 2018-2026 (USD MILLION)
FIGURE 12. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CORTICOSTERIODS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 13. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY NSAIDS, 2018-2026 (USD MILLION)
FIGURE 14. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY NSAIDS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 15. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY VISCOSUPPLEMENTATION, 2018-2026 (USD MILLION)
FIGURE 16. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY VISCOSUPPLEMENTATION, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 17. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (%)
FIGURE 18. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (USD MILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2026
FIGURE 20. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2026 (USD MILLION)
FIGURE 21. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 22. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2026 (USD MILLION)
FIGURE 23. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ONLINE PHARMACIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 24. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY RETAIL PHARMACIES, 2018-2026 (USD MILLION)
FIGURE 25. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 26. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2026 (%)
FIGURE 27. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2026 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2026
FIGURE 29. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2026 (USD MILLION)
FIGURE 30. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 31. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PARENTERAL, 2018-2026 (USD MILLION)
FIGURE 32. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PARENTERAL, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 33. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2026 (USD MILLION)
FIGURE 34. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 35. CALIFORNIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 36. FLORIDA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 37. ILLINOIS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 38. NEW YORK OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 39. OHIO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 40. PENNSYLVANIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 41. TEXAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 42. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET: FPNV POSITIONING MATRIX
FIGURE 43. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 44. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET, BY TYPE

List of Tables
TABLE 1. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CORTICOSTERIODS, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY NSAIDS, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY VISCOSUPPLEMENTATION, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ONLINE PHARMACIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PARENTERAL, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. CALIFORNIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 17. FLORIDA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 18. ILLINOIS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 19. NEW YORK OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 20. OHIO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. PENNSYLVANIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. TEXAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET: SCORES
TABLE 24. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET: BUSINESS STRATEGY
TABLE 25. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET: PRODUCT SATISFACTION
TABLE 26. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET: RANKING
TABLE 27. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 28. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET: MERGER & ACQUISITION
TABLE 29. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 30. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 31. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET: INVESTMENT & FUNDING
TABLE 32. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 33. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll